# 2025-02738: Patheon to Mass-Produce Magic Mushroom Chemicals

2025-02738, Bulk Manufacturer of Controlled Substances Application: Patheon API Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-02-18, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 21, 2025. Such persons may also file a written request for a hearing on the application on or before April 21, 2025. (as of 2026-09-24).

- Canonical: https://policyrisk.com/federal-register/2025-02738
- As of: 2026-09-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-02738
- Title: Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 9733
- Published: 2025-02-18
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 21, 2025. Such persons may also file a written request for a hearing on the application on or before April 21, 2025.
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-24

## In one line

Patheon to Mass-Produce Magic Mushroom Chemicals

## Summary

Patheon API Inc. wants to become a big-time maker of special research drugs called psilocybin and psilocyn. They plan to import these substances to help with science and medicine, not to sell or distribute them. If you have thoughts or want a hearing, you’ve got until April 21, 2025, to speak up!

## Abstract

Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-02738 on federalregister.gov](https://www.federalregister.gov/documents/2025/02/18/2025-02738/bulk-manufacturer-of-controlled-substances-application-patheon-api-inc)
- [2025-02738 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-02-18/pdf/2025-02738.pdf)

## Related
- [Previous: 2025-02737, Importer of Controlled Substances Application: Lonza Tampa, LLC](https://policyrisk.com/federal-register/2025-02737)
- [Next: 2025-02739, Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Ins…](https://policyrisk.com/federal-register/2025-02739)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-02738 (as of 2026-09-24).
